Increased diffusion in the normal appearing white matter of brain tumor patients: is this just tumor infiltration?

Journal of Neuro-Oncology

Volumn 127, Issue 1, 2016, Pages 83-90

  Horváth, Andrea ^a,b   Perlaki, Gábor ^a,b   Tóth, Arnold ^a,b   Orsi, Gergely ^a,b   Nagy, Szilvia ^a,b   Dóczi, Tamás ^b   Horváth, Zsolt ^b   Bogner, Péter ^a,b  

^a Diagnostic Center of Pecs   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

Author keywords

ADC; Glioma; Infiltration; Meningioma; Normal appearing white matter

Indexed keywords

ADULT; ARTICLE; CANCER GRADING; CANCER INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FEMALE; GLIOMA; HEMISPHERE; HUMAN; IMAGE ANALYSIS; IMAGING SOFTWARE; MALE; MENINGIOMA; MULTIPLE LINEAR REGRESSION ANALYSIS; NUCLEAR MAGNETIC RESONANCE SCANNER; RANK SUM TEST; RETROSPECTIVE STUDY; TUMOR VOLUME; WHITE MATTER; BRAIN TUMOR; CANCER STAGING; CASE CONTROL STUDY; COMPARATIVE STUDY; COMPUTER ASSISTED DIAGNOSIS; FOLLOW UP; MIDDLE AGED; PATHOLOGY; PROCEDURES; PROGNOSIS; STATISTICAL MODEL;

BRAIN NEOPLASMS; CASE-CONTROL STUDIES; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LINEAR MODELS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; WHITE MATTER;

EID: 84959361470     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-015-2011-y     Document Type: Article

References (37)

1. Puttick S, Bell C, Dowson N, Rose S, Fay M (2014) PET, MRI, and simultaneous PET/MRI in the development of diagnostic and therapeutic strategies for glioma. Drug Discov Today. doi:10.1016/j.drudis.2014.10.016
2. Law M, Yang S, Wang H, Babb JS, Johnson G, Cha S, Knopp EA, Zagzag D (2003) Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 24:1989–1998
3. Larsen VA, Simonsen HJ, Law I, Larsson HB, Hansen AE (2013) Evaluation of dynamic contrast-enhanced T1-weighted perfusion MRI in the differentiation of tumor recurrence from radiation necrosis. Neuroradiology 55:361–369. doi:10.1007/s00234-012-1127-4
4. Roy B, Gupta RK, Maudsley AA, Awasthi R, Sheriff S, Gu M, Husain N, Mohakud S, Behari S, Pandey CM, Rathore RK, Spielman DM, Alger JR (2013) Utility of multiparametric 3-T MRI for glioma characterization. Neuroradiology 55:603–613. doi:10.1007/s00234-013-1145-x
5. Cha S (2006) Update on brain tumor imaging: from anatomy to physiology. AJNR Am J Neuroradiol 27:475–487
6. Essig M, Anzalone N, Combs SE, Dorfler A, Lee SK, Picozzi P, Rovira A, Weller M, Law M (2012) MR imaging of neoplastic central nervous system lesions: review and recommendations for current practice. AJNR Am J Neuroradiol 33:803–817. doi:10.3174/ajnr.A2640
7. Essig M, Nguyen TB, Shiroishi MS, Saake M, Provenzale JM, Enterline DS, Anzalone N, Dorfler A, Rovira A, Wintermark M, Law M (2013) Perfusion MRI: the five most frequently asked clinical questions. AJR Am J Roentgenol 201:W495–W510. doi:10.2214/AJR.12.9544
8. Olson JJ, Nayak L, Ormond DR, Wen PY, Kalkanis SN, Ryken TC (2014) The role of targeted therapies in the management of progressive glioblastoma: a systematic review and evidence-based clinical practice guideline. J Neurooncol 118:557–599
9. Louis D, Ohgaki H, Wiestler O, Cavenee W, Burger P, Jouvet A, Scheithauer B, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97–109. doi:10.1007/s00401-007-0243-4
10. Stupp R, Roila F, Group ObotEGW (2009) Malignant glioma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Ann Oncol 20:iv126–iv128. doi:10.1093/annonc/mdp151
11. Ma C, Zhao G, Cruz MH, Siden A, Yakisich JS (2014) Translational gap in glioma research. Anticancer Agents Med Chem 14:1110–1120
12. Giese A, Bjerkvig R, Berens ME, Westphal M (2003) Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol 21:1624–1636. doi:10.1200/JCO.2003.05.063
13. Sahm F, Capper D, Jeibmann A, Habel A, Paulus W, Troost D, von Deimling A (2012) Addressing diffuse glioma as a systemic brain disease with single-cell analysis. Arch Neurol 69:523–526. doi:10.1001/archneurol.2011.2910
14. Inglese M, Brown S, Johnson G, Law M, Knopp E, Gonen O (2006) Whole-brain N-acetylaspartate spectroscopy and diffusion tensor imaging in patients with newly diagnosed gliomas: a preliminary study. AJNR Am J Neuroradiol 27:2137–2140
15. Kallenberg K, Goldmann T, Menke J, Strik H, Bock HC, Mohr A, Buhk JH, Frahm J, Dechent P, Knauth M (2014) Abnormalities in the normal appearing white matter of the cerebral hemisphere contralateral to a malignant brain tumor detected by diffusion tensor imaging. Folia neuropathol/Association of Polish Neuropathologists and Medical Research Centre, Polish Academy of Sciences 52:226–233
16. Cohen BA, Knopp EA, Rusinek H, Babb JS, Zagzag D, Gonen O (2005) Assessing global invasion of newly diagnosed glial tumors with whole-brain proton MR spectroscopy. AJNR Am J Neuroradiol 26:2170–2177
17. Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, van der Kouwe A, Killiany R, Kennedy D, Klaveness S, Montillo A, Makris N, Rosen B, Dale AM (2002) Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 33:341–355
18. Jenkinson M, Bannister P, Brady M, Smith S (2002) Improved optimization for the robust and accurate linear registration and motion correction of brain images. NeuroImage 17:825–841
19. Fedorov A, Beichel R, Kalpathy-Cramer J, Finet J, Fillion-Robin JC, Pujol S, Bauer C, Jennings D, Fennessy F, Sonka M, Buatti J, Aylward S, Miller JV, Pieper S, Kikinis R (2012) 3D Slicer as an image computing platform for the Quantitative Imaging Network. Magn Reson Imaging 30:1323–1341. doi:10.1016/j.mri.2012.05.001
20. Chan YH (2004) Biostatistics 201: linear regression analysis. Singapore Med J 45:55–61
21. Maudsley AA, Roy B, Gupta RK, Sheriff S, Awasthi R, Gu M, Husain N, Mohakud S, Behari S, Spielman DM (2013) Association of metabolite concentrations and water diffusivity in normal appearing brain tissue with glioma grade. J Neuroimaging. doi:10.1111/jon.12063
22. Nagy SA, Aradi M, Orsi G, Perlaki G, Kamson DO, Mike A, Komaromy H, Schwarcz A, Kovacs A, Janszky J, Pfund Z, Illes Z, Bogner P (2013) Bi-exponential diffusion signal decay in normal appearing white matter of multiple sclerosis. Magn Reson Imaging 31:286–295. doi:10.1016/j.mri.2012.07.007
23. Naganawa S, Sato K, Katagiri T, Mimura T, Ishigaki T (2003) Regional ADC values of the normal brain: differences due to age, gender, and laterality. Eur Radiol 13:6–11. doi:10.1007/s00330-002-1549-1
24. Orsi G, Aradi M, Nagy SA, Perlaki G, Trauninger A, Bogner P, Janszky J, Illés Z, Dóczi T, Pfund Z, Schwarcz A (2014) Differentiating white matter lesions in multiple sclerosis and migraine using monoexponential and biexponential diffusion measurements. J Magn Reson Imaging. doi:10.1002/jmri.24580
25. Bieza A, Krumina G (2012) Magnetic resonance study on fractional anisotropy and neuronal metabolite ratios in peritumoral area of cerebral gliomas. Medicina (Kaunas) 48:497–506
26. Provenzale JM, McGraw P, Mhatre P, Guo AC, Delong D (2004) Peritumoral brain regions in gliomas and meningiomas: investigation with isotropic diffusion-weighted MR imaging and diffusion-tensor MR imaging. Radiology 232:451–460. doi:10.1148/radiol.2322030959
27. Romano A, Fasoli F, Ferrante M, Ferrante L, Fantozzi LM, Bozzao A (2008) Fiber density index, fractional anisotropy, adc and clinical motor findings in the white matter of patients with glioblastoma. Eur Radiol 18:331–336. doi:10.1007/s00330-007-0740-9
28. Toh CH, Wong AM, Wei KC, Ng SH, Wong HF, Wan YL (2007) Peritumoral edema of meningiomas and metastatic brain tumors: differences in diffusion characteristics evaluated with diffusion-tensor MR imaging. Neuroradiology 49:489–494. doi:10.1007/s00234-007-0214-4
29. Lu S, Ahn D, Johnson G, Cha S (2003) Peritumoral diffusion tensor imaging of high-grade gliomas and metastatic brain tumors. AJNR Am J Neuroradiol 24:937–941
30. Morita K, Matsuzawa H, Fujii Y, Tanaka R, Kwee IL, Nakada T (2005) Diffusion tensor analysis of peritumoral edema using lambda chart analysis indicative of the heterogeneity of the microstructure within edema. J Neurosurg 102:336–341. doi:10.3171/jns.2005.102.2.0336
31. Nassehi D (2013) Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema. Dan Med J 60:B4626
32. Tsai JC, Teng LJ, Chen CT, Hong TM, Goldman CK, Gillespie GY (2003) Protein kinase C mediates induced secretion of vascular endothelial growth factor by human glioma cells. Biochem Biophys Res Commun 309:952–960
33. Van Meir E, Sawamura Y, Diserens AC, Hamou MF, de Tribolet N (1990) Human glioblastoma cells release interleukin 6 in vivo and in vitro. Cancer Res 50:6683–6688
34. Todo T, Adams EF, Rafferty B, Fahlbusch R, Dingermann T, Werner H (1994) Secretion of interleukin-6 by human meningioma cells: possible autocrine inhibitory regulation of neoplastic cell growth. J Neurosurg 81:394–401. doi:10.3171/jns.1994.81.3.0394
35. Black KL, Chen K, Becker DP, Merrill JE (1992) Inflammatory leukocytes associated with increased immunosuppression by glioblastoma. J Neurosurg 77:120–126. doi:10.3171/jns.1992.77.1.0120
36. Pauleit D, Langen KJ, Floeth F, Hautzel H, Riemenschneider MJ, Reifenberger G, Shah NJ, Muller HW (2004) Can the apparent diffusion coefficient be used as a noninvasive parameter to distinguish tumor tissue from peritumoral tissue in cerebral gliomas? J Magn Reson Imaging 20:758–764. doi:10.1002/jmri.20177
37. Rochfort KD, Cummins PM (2015) The blood-brain barrier endothelium: a target for pro-inflammatory cytokines. Biochem Soc Trans 43:702–706. doi:10.1042/BST20140319